Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders
Published on: September 6, 2024
Replenished microglia partially rescue schizophrenia-related stress response
Ling Yan1, Fang-Ling Xuan1, Song Chen2
1Institute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, Tartu, Estonia.
Background:
Microglia play an important role in the maintenance of brain and behavioral homeostasis. The protective effect of microglial replenishment was reported in neurological diseases, but whether microglial therapy would benefit psychiatric disorders such as schizophrenia has been unclear. As schizophrenia is a stress-vulnerable disorder and psychosocial stress promotes inflammation and microglial activation, we aim to understand how microglial replenishment works in stress-associated schizophrenia.
Methods:
We used a CSF1R-mediated pharmacological approach to study repopulated microglia (repMg) in a cohort of mice (n = 10/group) undergoing chronic unpredictable stress (CUS). We further studied a cohort of first-episode schizophrenia (FES, n = 74) patients who had higher perceived stress scores (PSS) than healthy controls (HCs, n = 68).
Results:
Reborn microglia attenuated CUS-induced learned hopelessness and social withdrawal but not anxiety in mice. Compared to control, CUS- or repMg-induced differentially expressed genes (DEGs) in the prefrontal cortex regulated nervous system development and axonal guidance. CUS also caused microglial hyper-ramification and increased engulfment of synaptophysin and vesicular glutamate transporter-2 by microglia and astrocytes, which were recovered in CUS + repMg (all p < 0.05). Moreover, FES patients had smaller hippocampal fimbria than HCs (p < 1e-7), which were negatively associated with PSS (r = -0.397, p = 0.003). Blood DEGs involved in immune system development were also associated with PSS and the right fimbria more prominently in FES patients than HCs (Zr, p < 0.0001). The KCNQ1 was a partial mediator between PSS and fimbria size (β = -0.442, 95% CI: -1.326 ~ -0.087).
Conclusion:
Microglial replenishment may potentially benefit psychiatric disorders such as schizophrenia.
Insights
Microglial replenishment shows promise for treating schizophrenia by improving stress-induced behavioral deficits and brain changes. This therapy may help restore brain homeostasis in psychiatric disorders.
Area of Science:
- Neuroscience
- Psychiatry
- Immunology
Background:
- Microglia are crucial for brain and behavioral stability.
- Microglial replenishment has shown benefits in neurological diseases.
- Its efficacy in psychiatric disorders like schizophrenia, particularly stress-related forms, remains unclear.
Purpose of the Study:
- To investigate the therapeutic potential of microglial replenishment in stress-associated schizophrenia.
- To understand the mechanisms underlying microglial replenishment in the context of chronic stress.
Main Methods:
- Utilized a CSF1R-mediated pharmacological approach for microglial replenishment in mice under chronic unpredictable stress (CUS).
- Examined a cohort of first-episode schizophrenia (FES) patients and healthy controls (HCs), assessing perceived stress scores (PSS) and hippocampal fimbria size.
- Analyzed differentially expressed genes (DEGs) in the prefrontal cortex and blood, and microglial morphology.
Main Results:
- Microglial replenishment (repMg) mitigated CUS-induced learned hopelessness and social withdrawal in mice, but not anxiety.
- CUS and repMg altered gene expression in the prefrontal cortex related to nervous system development and axonal guidance.
- CUS induced microglial hyper-ramification and increased engulfment of synaptic components, which were reversed by repMg.
- FES patients exhibited smaller hippocampal fimbria, negatively correlated with PSS.
- Blood DEGs involved in immune system development were associated with PSS and fimbria size in FES patients.
Conclusions:
- Microglial replenishment may offer a potential therapeutic strategy for psychiatric disorders like schizophrenia.
- The findings suggest a role for microglial function and immune system pathways in the pathophysiology of stress-related schizophrenia.
More Related Videos
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
07:13The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
Published on: October 24, 2018
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychoneuroimmunology: Diabetes and Cancer
Hypothalamic-Pituitary Axis